Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Positive crawled time : 17:00 save search
Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder Following Positive Results of PALISADE-2
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
VTGN | $4.83 1.05% 1.04% 190K
|
Health Technology
|
| O: -2.27%
H: 0.0%
C: 0.0%
positive treatment results study
J&J Touts Positive Phase III Results for Antibody in Autoimmune Disorders
Published: 2024-02-06 (Crawled : 17:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
antibody positive disorders results
Treace Announces Interim 3-Year ALIGN3D™ Clinical Study Data at the 2024 ACFAS Scientific Conference Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure
Published: 2024-02-02 (Crawled : 17:00) - globenewswire.com
TMCI | $10.84 -2.34% -2.4% 260K
|
Manufacturing
|
| O: -1.97%
H: 2.44%
C: 0.86%
lapiplasty conference positive study
Positive Phase 1/2 Clinical Trial Data for an Investigational Gene Therapy for Genetic Hearing Loss to be Presented at the Association for Research in Otolaryngology 2024 MidWinter Meeting
Published: 2024-01-23 (Crawled : 17:00) - prnewswire.com
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: -0.51%
H: 0.37%
C: 0.32%
genetic association positive research meeting trial therapy
Syndax Presents Positive Data from Pivotal AUGMENT-101 Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia at Late-Breaking Oral Presentation During 65th ASH Annual Meeting
Published: 2023-12-12 (Crawled : 17:00) - prnewswire.com
SNDX | $20.95 -0.05% -0.05% 870K
|
Health Technology
|
| O: -0.56%
H: 1.57%
C: -0.95%
gment-101 presentation positive meeting leukemia trial
Nurix Therapeutics Presents Positive Clinical Data from Its Novel Bruton’s Tyrosine Kinase (BTK) Degrader Programs, NX-5948 and NX-2127, at the 65th American Society of Hematology (ASH) Annual Meeting
Published: 2023-12-11 (Crawled : 17:00) - globenewswire.com
NRIX 6 d | $14.125 4.01% 3.86% 690K
|
Health Technology
|
| O: -0.7%
H: 0.23%
C: -1.52%
nx-5948 positive meeting therapeutics
Weight loss MEAI: Clearmind Medicine’s Novel Obesity Drug Showed Positive Results in a Pre-Clinical Trial
Published: 2023-12-01 (Crawled : 17:00) - globenewswire.com
CMND | $1.19 -1.28% 30K
|
n/a
|
| O: 20.86%
H: 21.75%
C: -2.13%
obesity drug pre-clinical positive trial results
Regeneron and Sanofi Find Further Positive Results for Dupixent in COPD
Published: 2023-11-27 (Crawled : 17:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: 1.04%
H: 0.17%
C: 0.11%
dupixent positive copd results sanofi
enVVeno Medical Presents Positive Preliminary Device Related Material Adverse Event (MAE) Data from the VenoValve Pivotal Trial at the 50th Annual VEITH Symposium
Published: 2023-11-16 (Crawled : 17:00) - biospace.com/
NVNO | $5.53 12.63% 11.21% 140K
|
Manufacturing
|
| O: 0.42%
H: 3.16%
C: -6.32%
device venovalve symposium positive medical trial
Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology
Published: 2023-11-13 (Crawled : 17:00) - biospace.com/
EQ | $1.77 7.27% 6.78% 88K
|
Health Technology
|
| O: 0.08%
H: 6.43%
C: 0.81%
positive meeting study
Novavax's Updated Nuvaxovid™ COVID-19 Vaccine Receives Positive CHMP Opinion in the EU
Published: 2023-10-31 (Crawled : 17:00) - prnewswire.com
NVAX | $4.205 3.32% 3.21% 3.6M
|
Health Technology
|
| O: -0.46%
H: 5.24%
C: 2.62%
covid-19 chmp vaccine positive
Magenta Medical Reports Positive Results for US Early Feasibility Study of Elevate™ Heart Pump in Providing Temporary Mechanical Circulatory Support During High-Risk PCI Procedures Results presented at TCT 2023 in San Francisco
Published: 2023-10-25 (Crawled : 17:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 0.0%
H: 0.0%
C: 0.0%
positive heart medical results study
Kronos Bio Presents Positive Preliminary Data from Phase 1 Dose Escalation Portion of Phase 1/2 KB-0742 Study at AACR-NCI-EORTC
Published: 2023-10-13 (Crawled : 17:00) - globenewswire.com
KRON | $0.9553 -0.49% -0.49% 4.3M
|
Health Technology
|
| O: 1.74%
H: 8.55%
C: -15.17%
kb-0742 positive study
TransCode Therapeutics Announces Positive Pre-Clinical Glioblastoma Results with Lead Therapeutic Candidate, TTX-MC138Further Supports TTX-MC138 Application in Brain Cancer
Published: 2023-09-25 (Crawled : 17:00) - biospace.com/
RNAZ | $0.461 0.44% 0.43% 100K
|
Professional, Scientific, and T...
|
| O: 97.29%
H: 144.27%
C: 94.66%
mc138 ttx-mc138 pre-clinical positive cancer application therapeutics results glioblastoma
Artelo Biosciences Completes Positive Pre-IND Meeting with FDA for ART26.12Announces Plans to File IND Application in Neuropathic Pain
Published: 2023-09-07 (Crawled : 17:00) - biospace.com/
ARTL | News | $1.3004 1.87% 15K
|
Health Technology
|
| O: 3.83%
H: 22.13%
C: -25.45%
art26 fda positive meeting application
GN Store Nord delivered strong organic growth in GN Hearing and solid sequential growth in GN Audio generating DKK 622 million positive free cash flow. Financial guidance updated
Published: 2023-08-16 (Crawled : 17:00) - globenewswire.com
GNNDY | $78.27 75.95% 200
|
n/a
|
| O: 0.12%
H: 0.59%
C: -0.58%
organic free positive audio financial store growth
Hoth Therapeutics Announces Positive Preclinical End Point Results of HT-ALZ Treatment for Alzheimer's Disease
Published: 2023-08-09 (Crawled : 17:00) - biospace.com/
HOTH | $1.15 1.2% 29K
|
Health Technology
|
| O: 8.89%
H: 2.04%
C: 2.04%
disease positive treatment preclinical alzheimer's therapeutics ht-alz results
C21 Investments Announces Q1 Results Revenue up 9.4% and Generated a Sixteenth Consecutive Quarter of Positive Free Cash Flow
Published: 2023-06-29 (Crawled : 17:00) - cxxi.ca
CXXIF | $0.298 -10.53% 15K
|
Process Industries
|
| O: 3.67%
H: 0.0%
C: 0.0%
investments free positive flow results
C21 Investments Announces Unaudited Year End Results, Generated a Fifteenth Consecutive Quarter of Positive Free Cash Flow in Q4
Published: 2023-06-02 (Crawled : 17:00) - cxxi.ca
CXXIF | $0.298 -10.53% 15K
|
Process Industries
|
| O: 1.62%
H: 15.9%
C: 13.55%
investments free year positive flow
BELLUS Health Announces Positive Results from its Phase 1 Bioavailability Equivalence Study Evaluating Once-Daily Extended-Release Formulation of Camlipixant in Comparison to Twice-Daily Immediate Release Formulation
Published: 2023-04-05 (Crawled : 17:00) - biospace.com/
BLU | $14.74 0.03% 0
|
Health Technology
|
| O: 0.87%
H: 0.72%
C: -6.92%
health positive results study blu-5937 camlipixant
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.